- Home
- XERS vs BRSP Comparison
XERS vs BRSP Comparison
Compare XERS & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- BRSP
- Stock Information
- Founded
- XERS 2005
- BRSP 2017
- Country
- XERS United States
- BRSP United States
- Employees
- XERS N/A
- BRSP N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- BRSP Real Estate Investment Trusts
- Sector
- XERS Health Care
- BRSP Real Estate
- Exchange
- XERS Nasdaq
- BRSP Nasdaq
- Market Cap
- XERS 752.7M
- BRSP 665.4M
- IPO Year
- XERS 2018
- BRSP 2018
- Fundamental
- Price
- XERS $5.49
- BRSP $5.30
- Analyst Decision
- XERS Strong Buy
- BRSP Buy
- Analyst Count
- XERS 6
- BRSP 4
- Target Price
- XERS $6.25
- BRSP $6.38
- AVG Volume (30 Days)
- XERS 1.8M
- BRSP 834.2K
- Earning Date
- XERS 08-07-2025
- BRSP 07-29-2025
- Dividend Yield
- XERS N/A
- BRSP 12.05%
- EPS Growth
- XERS N/A
- BRSP N/A
- EPS
- XERS N/A
- BRSP N/A
- Revenue
- XERS $222,551,000.00
- BRSP $335,107,000.00
- Revenue This Year
- XERS $35.31
- BRSP N/A
- Revenue Next Year
- XERS $19.65
- BRSP $9.97
- P/E Ratio
- XERS N/A
- BRSP N/A
- Revenue Growth
- XERS 29.88
- BRSP N/A
- 52 Week Low
- XERS $2.10
- BRSP $4.16
- 52 Week High
- XERS $6.07
- BRSP $6.45
- Technical
- Relative Strength Index (RSI)
- XERS 62.75
- BRSP 62.24
- Support Level
- XERS $4.94
- BRSP $4.87
- Resistance Level
- XERS $5.22
- BRSP $5.32
- Average True Range (ATR)
- XERS 0.22
- BRSP 0.13
- MACD
- XERS -0.01
- BRSP 0.04
- Stochastic Oscillator
- XERS 86.44
- BRSP 86.87
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.